To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses and important links click here.
For more information on this topic, please visit the Real Time Learning Network
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.
Topics: COVID-19 Vaccine Boosters, the Immune Compromised & Protecting the Most Vulnerable
Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts:
COVID-19 Boosters Update:
Perspectives from VRBPAC
Archana Chatterjee, MD, PhD
Dean, Chicago Medical School
Vice President for Medical Affairs
Rosalind Franklin University
Member, Vaccines and Related Biological Products Advisory Committee
FDA Update
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation & Research
U.S. Food and Drug Administration
ACIP Clinical Considerations & Recommendations
Sarah Mbaeyi, MD, MPH
Chief Medical Officer, COVID-19 Vaccine Task Force
Centers for Disease Control and Prevention
Kimberley Fox, MD, MPH
Captain, U.S. Public Health Service
Vaccine Task Force Co-Lead
Centers for Disease Control and Prevention COVID-19 Response
Protecting Our Most Vulnerable — Focus on the Immune Compromised:
Strategies for Prevention & Treatment
Lawrence Corey, MD
Co-PI, COVID-19 Prevention Network (CoVPN)
Professor of Medicine and Laboratory Medicine
Fred Hutchinson Cancer Center and University of Washington
Myron S. Cohen, MD
Yeargan-Bate Professor of Medicine, Microbiology and Epidemiology
Associate Vice Chancellor for Medical Affairs and Global Health
Director, Institute for Global Health and Infectious
University of North Carolina at Chapel Hill
COVID-19 in Patients with Cancer: A Uniquely Vulnerable Population
Jeremy Warner, MD, MS, FAMIA, FASCO
Associate Professor of Medicine (Hematology/Oncology) and Biomedical Informatics
Vanderbilt University
Co-Founder and Steering Committee Member
COVID-19 and Cancer Consortium (CCC19)
Director, CCC19 Research Coordinating Center
